Home › Articles › Volume 8, Issue 1 › The Prognostic Factors for Locally Advanced cervical...
Moradabad, India
Original Article
Radiation Oncology

The Prognostic Factors for Locally Advanced cervical Cancer Patients Treated by Cisplatin Based Concurrent Chemoradiotherpy- A Retrospective Study


Volume 8, Issue 1, Pages 5-9

Authors

S. Jeeva1, V. Arun Ramanan2, Sowmiya. KR3, P. Balasubramaniam4, Vidya5, Chandralekha6
Affiliation:
1Associate Professor, Department of Radiation Oncology, Tamilnadu Government Multi Superspecialty Hospital, Chennai,
2Assistant Professor, Department of Medical Oncology, Tamilnadu Government Multi Super specialty Hospital, Chennai,
3Professor, Department of community medicine, Chettinad Hospital and research institute (CARE), Chennai,
4Professor, Department of Radiation Oncology, Tamilnadu Government Multi Superspecialty Hospital, Chennai,
5Assistant Professor, Department of Radiation Oncology, Tamilnadu Government Multi Superspecialty Hospital, Chennai,
6Registrar, Department of Radiation Oncology, Tamilnadu Government Multi Superspecialty Hospital, Chennai.

Corresponding Author

V. Arun Ramanan

Abstract

Background: Aim: To identify the prognostic factors for the locally advanced cancer cervix patients treated with weekly cisplatin based concurrent chemoradiation. Subjects and Methods: We have analyzed 57 women with FIGO stage IB2-IIIB cervical cancer treated in the Oncology outpatient department of a tertiary care center between May 2014 to December 2016.Inclusion criteria includes patients treated with Radical Radiotherapy with cisplatin 30mg/m2.Median total dose to point A was 72Gy. Data regarding age, performance status, stage, histology, grade, tumour size, pretreatment haemoglobin level, radiological imaging details, pelvic nodal involvement, compliance to treatment, no. of chemotherapy cycles, total duration of radiotherapy and toxicity profiles are reviewed from medical records. Primary endpoints were to assess the prognostic factors that affects the tumor response and progression free survival and disease free survival. Survival analysis was estimated using the Kaplan-Meier method and multivariate Cox proportional hazard model, to estimate the hazard ratio and 95% confidence intervals using IBM SPSS statistical software. Results: The median follow-up time was 18 months. The 2 year overall survival was 31.6% and PFS is 29.8%. In univariate analysis presence of pelvic node, tumor size, radiotherapy treatment duration, no. of chemotherapy cycles were significantly associated with overall survival and progression free survival. In multivariate analysis, only tumour size and radiotherapy treatment duration significantly affected the overall survival and progression free survival. Conclusion: Bulky tumour and prolongation of treatment duration were poor prognostic factors for patients with locally advanced cervical cancer. Chemotherapy with a high cumulative dose of cisplatin tended to result in better survival.

Keywords

Locally advanced cervical cancer, concurrent chemoradiation, weekly ciplatin.prognostic factors.

History

Received 01 February 2019

Accepted 01 February 2019

DOI

10.21276/ajmr.2019.8.1.MC2

Author Notes

Corresponding Author: Dr. V. Arun Ramanan, Assistant Professor, Department of Medical Oncology, Tamilnadu Government Multi Super specialty Hospital, Chennai.

Open Access

It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright: © the author(s), 2019.

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
9
Downloads
7
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 8
Issue Issue 1
Year 2019

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni